Challenging the “Pfizer mRNA Stays in the Arm” Narrative

For several years, public health agencies such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) stated that mRNA COVID-19 vaccines remain near the injection site and break down quickly after triggering an immune response.

Early clinical trial data for the Pfizer–BioNTech showed about 95% vaccine efficacy against symptomatic COVID-19 and a generally favorable short-term safety profile, which supported widespread use, including among pregnant women and older adults. These assurances shaped public understanding that the mRNA in vaccines would not circulate widely or reach reproductive tissues.

However, a newer peer-reviewed study entitled "Detection of Pfizer BioNTech Messenger RNA COVID-19 Vaccine in Human Blood, Placenta, and Semen,"revisited this assumption using more sensitive testing. Researchers detected Pfizer mRNA in blood, placental tissue, and sperm, sometimes months after vaccination, and in a small number of unvaccinated individuals. Detection alone does not prove harm, but it has prompted researchers to take a closer look at how mRNA vaccines are processed and move through the body.

Disclaimer: This article is for educational purposes and is not medical advice. Consult with a qualified healthcare provider for advice tailored to your situation.

Visual representation of autoimmune inflammation affecting multiple organs

How This Study Was Different: A More Sensitive Test

The findings reflect how this study was designed to answer questions that earlier research could not:

  • Detection limits in prior studies: Earlier research was not optimized to detect very small amounts of vaccine messenger RNA (mRNA) over long periods. Standard one-step PCR (quantitative polymerase chain reaction, qPCR) can miss low-level fragments that persist over time.
  • Use of nested PCR: Researchers employed nested PCR, a more sensitive two-step process, to detect small mRNA fragments that earlier studies might have overlooked.
  • Sequence confirmation with Sanger sequencing: The detected genetic material was verified with Sanger sequencing, confirming that positive samples matched the Pfizer-BioNTech mRNA sequence and not unrelated genetic material.
  • Strict criteria to reduce false positives: Only reproducible results were counted, limiting false positives.

Now, why does this matter? Standard PCR is like a basic metal detector for large objects, while nested PCR is a high-resolution scanner for smaller signals. This sensitivity explains why Pfizer's mRNA was detected in this study, unlike earlier vaccine research.

Key Findings: Pfizer mRNA COVID-19 Vaccine Found Throughout the Body

To better understand vaccine biodistribution, researchers from Bar-Ilan University and several Israeli medical centers analyzed tissue samples from 34 participants, including 22 pregnant women, 4 male sperm donors (with eight samples), and 8 additional adults, using nested PCR and Sanger sequencing.

They detected Pfizer‑BioNTech (Comirnaty) mRNA in 88% of pregnant women vaccinated within 100 days, in 100% of sperm‑producing male donors (with 50% also positive in seminal fluid), and in 50% of unvaccinated pregnant women.

Notably, approximately half of all participants still showed detectable mRNA more than 200 days after vaccination, indicating persistence that extends well beyond the immediate post-injection period.

The results are summarized below:

Study Finding Vaccine Candidate What Was Detected Timing Observed
mRNA in the placenta and blood Vaccinated pregnant women Pfizer mRNA in placental tissue and maternal blood Most within 100 days; some up to ~8 months
mRNA in sperm cells Vaccinated male donors Pfizer mRNA inside sperm cells Weeks to ~5.5 months after vaccination
mRNA in seminal fluid Subset of vaccinated men Pfizer mRNA in seminal plasma Within weeks of vaccination
Long-term persistence Vaccinated adults Circulating Pfizer mRNA >200 days after last dose
Detection in unvaccinated women (possible shedding) Unvaccinated pregnant women Pfizer mRNA in blood and/or placenta At the time of delivery

Detection of mRNA does not by itself prove harm or clinical risk. The authors emphasize that these findings highlight gaps in long-term human biodistribution data and underscore the need for additional, larger studies better to understand the implications of these observations for health outcomes.

Pfizer BioNTech Messenger RNA COVID-19 Vaccine Health Implications: Fertility, Immunity, and Beyond

The discovery of vaccine-related mRNA in placental tissue, reproductive cells, and a small number of unvaccinated individuals raises questions that researchers say warrant further study.

Pregnancy and Infant Health

Detecting mRNA in the placenta shows that vaccine-related material can reach pregnancy-associated tissues. This does not confirm harm, but it highlights why researchers continue to study pregnancy outcomes and infant health over more extended periods.

Fertility and Reproductive Health

The presence of mRNA in sperm and placental tissue has prompted additional research questions about reproductive biology. At this time, no direct link to infertility has been established, but longer-term data are still being collected.

Immune System Activity

mRNA vaccines are designed to activate immune cells for a limited time. If mRNA or spike protein remains detectable longer in some individuals, researchers are exploring whether this could contribute to prolonged immune activation or inflammation in a small subset of people.

Possible Shedding and Community Exposure

The detection of mRNA in some unvaccinated individuals suggests potential secondary exposure, although the mechanism is not yet understood. Scientists emphasize that more data are needed before concluding real-world impact.

What You Can Do: Protecting Your Health and Managing Spike Protein

Strategies for spike protein–related pathology from both COVID-19 infection and vaccines discuss a range of management ideas with varying levels of evidence, so it’s best to use them as a starting point for informed conversations, not self-treatment.

A simple strategy involves these four steps:

1. Fix Your Gut: Establish a Healthy Microbiome

Gut imbalance (dysbiosis) is common in individuals with persistent symptoms and affects immune regulation. The gut plays a key role in inflammation, detoxification, and immune signaling.

Focus on a whole-food, plant-forward diet to lower inflammation and reduce sugar and refined carbs, as high glucose may worsen symptoms. Include probiotic- and prebiotic-rich foods, like fermented vegetables and fiber-rich fruits, to restore microbial diversity.

In clinical practice, a detailed assessment to identify the specific root causes of gut imbalance, can help pinpoint imbalances that may contribute to ongoing symptoms.

2. Block the Attack: Prevent Spike Protein Effects

The goal is to stop the spike protein from binding to and harming your cells' ACE2 receptors. This is attempted using competitive inhibitors.

Some compounds, like Quercetin, may bind directly to the spike protein, while others—like Metformin—may occupy the ACE2 receptor on the cell's surface, effectively blocking the spike's access.

3. Body Detox: Clear the Spike Protein

Recovery may also depend on the body’s ability to degrade and clear residual spike protein through autophagy, the body’s cellular self-cleaning process. Autophagy can be supported through lifestyle strategies, such as calorie restriction, intermittent fasting, reduced protein intake, and avoidance of metabolic stressors.

Physical modalities that combine heat exposure and improved oxygen delivery have also been explored as supportive tools for detoxification and cellular recovery.

4. Repair & Soothe: Heal the Damage

The final phase focuses on calming chronic inflammation and supporting vascular repair, particularly when microclotting or endothelial stress is present. Nattokinase is often discussed for its fibrinolytic (clot-breaking) activity and its potential role in addressing abnormal protein structures observed in laboratory research.

To further support recovery, non-invasive therapies that promote cellular repair and help reduce inflammation may also play a supportive role.

Disclaimer: This article is for educational purposes and is not medical advice. Consult with a qualified healthcare provider for advice tailored to your situation.

Frequently Asked Questions

Some studies using highly sensitive tests have detected small fragments of vaccine mRNA weeks or months after vaccination. The implications are still being studied, and researchers are working to understand whether it has any meaningful health impact.

Yes, a peer-reviewed study reported detecting Pfizer mRNA in placental tissue, blood, and sperm using advanced laboratory methods. This finding does not confirm harm, but it helps explain why researchers continue to study long-term biodistribution.

In one small study, Pfizer mRNA was detected in 50% of unvaccinated pregnant women, including in blood and placental tissue. The authors note that the source of this RNA is unknown, and detection alone does not establish transmission or health effects.

U.S. agencies, such as the CDC and FDA, state that authorized mRNA vaccines have an overall favorable safety profile, based on clinical trials and ongoing monitoring. They continue to review new data as it becomes available.

Current guidance indicates spike protein production after vaccination is temporary for most people. If you have ongoing symptoms or concerns, discussing them with a qualified healthcare provider can help you decide the next steps.

Conclusion: A New Chapter in Understanding mRNA Vaccines

As research continues to evolve, you’re seeing a clearer picture of how mRNA vaccines behave in the body over time. New findings showing Pfizer mRNA beyond the injection site, including in blood and reproductive tissues, highlight why longer-term human data and drug discovery matter.

The key takeaway is awareness—not alarm.

Vaccines helped reduce severe disease and mortality, while staying informed about emerging evidence supports confident, informed health decisions that balance benefits with ongoing questions.

If you want help understanding or managing spike protein levels as part of your overall health, Internal Healing and Wellness MD offers individualized care guided by current evidence and your personal health history.

Relevant Studies and References

  • Centers for Disease Control and Prevention. (2023). Safety of COVID-19 vaccines. U.S. Department of Health and Human Services. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html
  • World Health Organization. (2023). Safety of COVID-19 vaccines. https://www.who.int/news-room/feature-stories/detail/safety-of-covid-19-vaccines
  • Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., … Gruber, W. C. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 383(27), 2603–2615. https://doi.org/10.1056/NEJMoa2034577
  • Mordechay, S., et al. (2025). Detection of Pfizer BioNTech messenger RNA COVID-19 vaccine in human blood, placenta, and semen. Annals of Case Reports. https://web.archive.org/web/20251206195037/https://www.gavinpublishers.com/article/view/detection-of-pfizer-biontech-messenger-rna-covid19-vaccine-in-human-blood-placenta-and-semen
  • Halma, M. T. J., Plothe, C., Marik, P., & Lawrie, T. A. (2023). Strategies for the management of spike protein-related pathology. Microorganisms, 11(5), 1308. https://doi.org/10.3390/microorganisms11051308